Year-over-year earnings per share growth for the last twelve months: LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics (LVTX) - corporate logo

The development of Gammabody antibodies and the collaboration with Merck have driven growth dynamics, as evidenced by the peak quarterly EPS growth in the indicator's chronology on the GURU.Markets chart, where the value stands at 41.20. LAVA Therapeutics N.V. (LVTX) further complements its strategy with sustainable production and bioethics, while access to capital through the Pfizer partnership and FDA oversight determine the scaling of the GAMA platform.

LAVA Therapeutics NV (LVTX) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 12/06/2025

Comprehensive metric breakdowns and analytics for LAVA Therapeutics (LVTX)

- company stock exchange capitalization indicators:
Comprehensive company analysis:LAVA Therapeutics N.V., LVTX
Manufactured product of lavatherapeutics.com

For LAVA Therapeutics N.V. (LVTX), which is developing innovative cancer immunotherapy, the earnings per share dynamics reflect the efficiency of capital management prior to the commercialization of intellectual property. The current value of 41.20 and the amplitude of quarterly EPS fluctuations measure the daily growth of net income, allowing investors to identify hidden operating costs and assess the risk balance before the company enters the stage of long-term profitability.

Competitors of LAVA Therapeutics N.V.

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lyell Immunopharma Inc (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma|ALX Oncology (ALXO) - Year-over-year earnings per share growth for the last twelve months|cuebiopharma.com (CUE) - Quarterly EPS earnings growth|PDSB (PDS Biotechnology Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth sonnetbio.com|Year-over-year earnings per share growth for the last twelve months MAIA Biotechnology, Inc. (MAIA)|LIMN: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP